SPYRE THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
SPYRE THERAPEUTICS, INC. (SYRE) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $314.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2017-05-09
- 2017-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $314.00K.
- 2016-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $50.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2017-03-31 | $314.00K 10-Q · filed 2017-05-09 |
| 2016-09-30 | $50.00K 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |